Licorice

Hook

Licorice is one of the herbs that looks softer than it is. The root is sweet, yes, but the strongest page keeps that sweetness tied to tissue protection, adrenal-style recovery language, and formula support rather than indulgence. Human relevance is real enough to matter, especially around mucosal support and certain inflammatory or endocrine-adjacent questions, but the page also has to keep blood pressure and long-term use cautions in plain sight. Licorice is nourishing for the right person and a mismatch for the wrong one. That conditionality is part of its authority.

What it is for

Glycyrrhiza glabra L., Fabaceae. Root and rhizome (stolons). Common names include licorice and liquorice. Called "The Great Harmonizer" in TCM, appearing in more classical formulations than any other herb. The root contains glycyrrhizin (glycyrrhizic acid, up to 20% of root dry weight), a triterpene saponin 60 times sweeter than sucrose, serving as both the primary bioactive and primary toxicity concern. Its active metabolite after gut bacterial hydrolysis is 18beta-glycyrrhetinic acid (GA). Additional compounds include glabridin (isoflavonoid), liquiritigenin (estrogenic and neuroprotective flavanone), isoliquiritigenin (antitumor chalcone), and licochalcone A. The critical mechanism involves cortisol metabolism. Glycyrrhetinic acid is a very high-affinity inhibitor of 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2), the enzyme that converts cortisol to inactive cortisone in mineralocorticoid-sensitive tissues including kidney, colon, and salivary glands. When inhibited, cortisol accumulates and binds mineralocorticoid receptors, producing pseudohyperaldosteronism. Serum cortisol tends to remain normal because the type 1 enzyme is not inhibited, but urinary free cortisol is elevated. Licorice does not increase cortisol production; it prevents cortisol inactivation in specific tissues. Anti-inflammatory activity involves NF-kappaB suppression through IkappaBalpha phosphorylation inhibition and MAPK cascade attenuation (ERK, p38, JNK), with effects comparable to glucocorticoids. GA also inhibits CYP3A (IC50 ~20.1 uM, mixed inhibition). Human clinical evidence documents both therapeutic and adverse effects. Japanese Adverse Drug Event Report analysis showed dose-dependent pseudoaldosteronism risk: ROR of 20.9 at less than 2.5g, 26.1 at 2.5-4.9g, and 147.3 at 5.0g or above, more frequent in females over 50 (Kato et al., 2015). Case reports document life-threatening hypokalemia with torsade de pointes from excessive consumption (Panduranga and Al-Rawahi, 2013). Therapeutically, glycyrrhizin promotes healing of stomach and mouth ulcers, with gastroprotective effects maintained in DGL (deglycyrrhizinated licorice) preparations that eliminate mineralocorticoid risk (Pastorino et al., 2018; Cherrada et al., 2024). Preclinical findings include reduction of TNF-alpha, IL-1beta, and IL-6 in spinal cord injury models. Glycyrrhizin is used clinically for chronic hepatitis in Japan and China, with antiviral activity against hepatitis and respiratory viruses.

Licorice is usually reached for when dryness, irritation, or depleted recovery need a moistening and protective answer. Demulcent-tonic is the useful reading, not candy confusion.